Skip to main content

Zacks Analyst Blog Highlights: Companhia Paranaense de Energia, Medtronic, Inc., Telephone & Data Systems, Inc., United States Cellular Corp. and McCormick & Schmick's Seafood Restaurants Inc.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Companhia Paranaense de Energia (NYSE: ELP), Medtronic, Inc. (NYSE: MDT), Telephone & Data Systems, Inc. (NYSE: TDS), United States Cellular Corp. (AMEX: USM) and McCormick & Schmicks Seafood Restaurants Inc. (Nasdaq: MSSR).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Fridays Analyst Blog:

COPEL's Big Near-Term Potential

We are keeping our Buy recommendation on Companhia Paranaense de Energia, or COPEL (NYSE: ELP). The company's second quarter results were positive, and the short-term outlook is also positive due to the company's various investments.

In addition, the Brazilian business environment remains encouraging; the energy consumption in Brazil is still heated; and the short-to-medium-term outlook for energy consumption in Brazil is very encouraging. Moreover, becoming a part of the São Paulo Stock Exchange's Level 1 of Corporate Governance will enhance the positive aspects of the company. Finally, COPEL shares are trading at an attractive valuation.

Medtronic Reaffirmed a Hold

Medtronic, Inc.s (NYSE: MDT) story is improving -- product approvals and launches and a renewed focus on operating margins should drive healthy near-term EPS growth. An increase in quarterly dividends and reiteration of guidance reaffirms our position on this stock. We leave our estimates unchanged and bring valuation closer in-line with peers.

Medtronic is a market leader in cardiology and spine devices that benefits from scale, resources and incremental sales synergies within the medical devices industry. The company is strengthening its position in neurology and stents, two high-growth markets. A deep product pipeline and strong R&D program leaves MDT well positioned for long-term organic growth, not relying purely upon acquisitions.

TDS Growth Engine US Cellular

We maintain our Hold recommendation for Telephone & Data Systems, Inc. (NYSE: TDS) following the release of recent quarterly results. The wireless business (U.S. Cellular AMEX: USM), driven by gains in service and data revenues, remains the growth engine for the company, which offset declines in wireline segment revenue and loss of physical access lines.

The company continues to maintain low churn (customer switch) while increasing operating return per subscriber. The management continues its share buyback initiative and has provided a positive outlook for 2008, focusing on improving profitability through network technology upgrades and strengthening its brand image.

McCormick & Schmicks Traffic Low

McCormick & Schmicks (Nasdaq: MSSR) is suffering declining traffic and comps as cash-squeezed consumers are dining out less. Early signals indicate that traffic may be stabilizing and we think historical levels of growth and profitability will resume when the economy recovers. Meanwhile, with debt-to-capital of just 12 percent, the company can comfortably continue its expansion plan, which has been greatly scaled back for 2009 to 6 units from 11 planned for 2008.

However, we think the management's 2008 EPS guidance of $0.64-0.74 is aggressive (the Wall Street consensus is $0.66). The guidance is very back-end loaded, incorporating substantial improvements in comps and margin expansion in the second half of the year, despite murky visibility. That said, we think the low end of guidance may be doable as MSSR laps poor back half of 2007 comps.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contacts:

Zacks.com
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.